Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study.

التفاصيل البيبلوغرافية
العنوان:	Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study.
المؤلفون:	Selvaraj, Divakar, Muthu, Santhoshkumar, Kotha, Satvik, Siddamsetty, Ramachandra Setty, Andavar, Sasikumar, Jayaraman, Saravanan
المصدر:	Journal of Biomolecular Structure & Dynamics; Feb2021, Vol. 39 Issue 2, p621-634, 14p
قاعدة البيانات:	Complementary Index

الوصف
تدمد:	07391102
DOI:	10.1080/07391102.2020.1715261